With MPs discussing the condition in Parliament this week, COVER investigates what advisers should be aware of when discussing diabetes with clients
While the idea of a diabetes debate in Parliament this week may seem a tad pointless with Brexit discussions still up in the air, it is not an issue we can afford to ignore - both in society and as an industry. Questions might remain around supplies of insulin in the UK post-EU, but another is the extent to which the protection and health industry can extend itself to provide better access to insurance to people suffering from type 1 and type 2 diabetes. Access Life cover is currently available...
To continue reading this article...
Join Cover
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around Covid-19, regulation, diversity and mental health.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Exclusive access to our fortnightly Protection insight mini-podcast.
- Be the first to hear about our CPD accredited events and awards programmes.
